OpenBilldrug price receipt

NADAC week of 2026-10-14

EPOGEN 10,000 UNIT/ML VIAL

FDA nonproprietary name: epoetin alfa

For 1 mL

Pharmacies pay

$161.80 filed

1 × $161.80013 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$179.43 filed

1 × $179.43423 per ML, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

1.1× estimated

Medicare paid 1.1× what pharmacies pay.

Part D averages every strength and form sold under “Epogen” / “Epoetin Alfa” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-09-30 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$191.07 estimated

$161.80 + $24.27 (15%) + $5.00 fee per fill = $191.07

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-09-30 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

EPOGEN 10,000 UNIT/ML VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as epoetin alfa, under the trade name “EPOGEN”.

FDA gives its dosage form as solution and its route as intravenous; subcutaneous.

The labeler, the company named on the label, is Amgen, Inc.

FDA’s Established Pharmacologic Class for it is Erythropoiesis-stimulating Agent.

The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes).

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $161.80 for 1 mL (1 × $161.80013 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-09-23 and 2026-09-30. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

All 2 NDCs

Other strengths, forms and brands

2 other products in the NADAC file share the FDA nonproprietary name epoetin alfa with EPOGEN 10,000 UNIT/ML VIAL.

ProductPharmacies pay per unitMedicare per unit
EPOGEN 2,000 UNITS/ML VIAL
brand · solution
$32.26688 per ML filed
eff. 2026-09-23
$179.43423 per ML filed
Part D 2024 average
EPOGEN 4,000 UNIT/ML VIAL
brand · solution
$64.3638 per ML filed
eff. 2025-12-17
$179.43423 per ML filed
Part D 2024 average
EPOGEN 10,000 UNIT/ML VIAL this page
brand · solution
$161.80013 per ML filed
eff. 2026-09-23 to 2026-09-30
$179.43423 per ML filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2025-12-17, 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 2 NDCs’ NADAC prices is $161.80013 per ML filed.

Of the 13 other products in FDA’s Erythropoiesis-stimulating Agent class priced per ML, 8 have a higher middle NADAC price and 5 a lower one. The one in the middle is PROCRIT 10,000 UNIT/ML VIAL, at $259.86093 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $179.43 for 1 mL, at an average of $179.43423 per ML in 2024 (2024-01-01 to 2024-12-31) for “Epogen” and “Epoetin Alfa”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 16,346 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for EPOGEN 10,000 UNIT/ML VIAL labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Epogen / Epoetin Alfa: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on brand name.
Why does this page start at 1 mL?
NADAC prices this product per ML. In the FDA NDC Directory, 2 of this product’s NDCs are wholesale packs of identical units, so OpenBill counts one unit of each; for example, NDC 55513-0144-10 (“10 VIAL in 1 PACKAGE (55513-144-10) / 1 mL in 1 VIAL (55513-144-01)”) is a package of 10 vials, 10 mL in all. So the card starts at one unit: 1 ML. Change it to match your prescription.